The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab
2017-01-01 Demurtas, L.; Puzzoni, M.; Giampieri, R.; Ziranu, P.; Pusceddu, V.; Mandolesi, A.; Cremolini, C.; Masi, G.; Gelsomino, F.; Antoniotti, C.; Loretelli, C.; Meriggi, F.; Zaniboni, A.; Falcone, A.; Cascinu, S.; Scartozzi, M.
Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW
2018-01-01 Muro, K.; Cho, J. Y.; Bodoky, G.; Goswami, C.; Chao, Y.; dos Santos, L. V.; Shimada, Y.; Topuzov, E.; Van Cutsem, E.; Tabernero, J.; Zalcberg, J.; Chau, I.; Cascinu, S.; Cheng, R.; Hsu, Y.; Emig, M.; Orlando, M.; Fuchs, C.
Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials
2018-01-01 Coccolini, F.; Nardi, M.; Montori, G.; Ceresoli, M.; Celotti, A.; Cascinu, S.; Fugazzola, P.; Tomasoni, M.; Glehen, O.; Catena, F.; Yonemura, Y.; Ansaloni, L.
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study
2018-01-01 Lazzaro, C.; Barone, C.; Caprioni, F.; Cascinu, S.; Falcone, A.; Maiello, E.; Milella, M.; Pinto, C.; Reni, M.; Tortora, G.
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study
2019-01-01 Van Cutsem, E.; Martinelli, E.; Cascinu, S.; Sobrero, A.; Banzi, M.; Seitz, J. -F.; Barone, C.; Ychou, M.; Peeters, M.; Brenner, B.; Hofheinz, R. D.; Maiello, E.; Andre, T.; Spallanzani, A.; Garcia-Carbonero, R.; Arriaga, Y. E.; Verma, U.; Grothey, A.; Kappeler, C.; Miriyala, A.; Kalmus, J.; Falcone, A.; Zaniboni, A.
The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials
2019-01-01 Cascinu, S.; Poli, D.; Zaniboni, A.; Lonardi, S.; Labianca, R.; Sobrero, A.; Rosati, G.; Di Bartolomeo, M.; Scartozzi, M.; Zagonel, V.; Pella, N.; Banzi, M.; Torri, V.
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series
2019-01-01 Negri, F.; De Giorgi, A.; Gilli, A.; Azzoni, C.; Bottarelli, L.; Gnetti, L.; Goldoni, M.; Manotti, L.; Sgargi, P.; Michiara, M.; Leonardi, F.; Rindi, G.; Cascinu, S.; Silini, E. M.
Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy
2019-01-01 Giampieri, R.; Piva, F.; Occhipinti, G.; Bittoni, A.; Righetti, A.; Pagliaretta, S.; Murrone, A.; Bianchi, F.; Amantini, C.; Giulietti, M.; Ricci, G.; Principato, G.; Santoni, G.; Berardi, R.; Cascinu, S.
Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?
2019-01-01 Palmerini, E.; Torricelli, E.; Cascinu, S.; Pierini, M.; De Paolis, M.; Donati, D.; Cesari, M.; Longhi, A.; Abate, M.; Paioli, A.; Setola, E.; Ferrari, S.
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy
2019-01-01 Salati, M.; Caputo, F.; Cunningham, D.; Marcheselli, L.; Spallanzani, A.; Rimini, M.; Gelsomino, F.; Reggiani-Bonetti, L.; Andrikou, K.; Rovinelli, F.; Smyth, E.; Baratelli, C.; Kouvelakis, K.; Kalaitzaki, R.; Gillbanks, A.; Michalarea, V.; Cascinu, S.; Braconi, C.
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study
2019-01-01 Loupakis, F.; Intini, R.; Cremolini, C.; Orlandi, A.; Sartore-Bianchi, A.; Pietrantonio, F.; Pella, N.; Spallanzani, A.; Dell'Aquila, E.; Scartozzi, M.; De Luca, E.; Rimassa, L.; Formica, V.; Leone, F.; Calvetti, L.; Aprile, G.; Antonuzzo, L.; Urbano, F.; Prenen, H.; Negri, F.; Di Donato, S.; Buonandi, P.; Tomasello, G.; Avallone, A.; Zustovich, F.; Moretto, R.; Antoniotti, C.; Salvatore, L.; Calegari, M. A.; Siena, S.; Morano, F.; Ongaro, E.; Cascinu, S.; Santini, D.; Ziranu, P.; Schirripa, M.; Buggin, F.; Prete, A. A.; Depetris, I.; Biason, P.; Lonardi, S.; Zagonel, V.; Fassan, M.; Di Maio, M.
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients
2019-01-01 Weide, B.; Eigentler, T.; Catania, C.; Ascierto, P. A.; Cascinu, S.; Becker, J. C.; Hauschild, A.; Romanini, A.; Danielli, R.; Dummer, R.; Trefzer, U.; Elia, G.; Neri, D.; Garbe, C.
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer
2019-01-01 Negri, F.; Bozzetti, C.; Pedrazzi, G.; Azzoni, C.; Bottarelli, L.; Squadrilli, A.; Lagrasta, C.; Tamagnini, I.; Bisagni, A.; Ragazzi, M.; Porzio, R.; Tomasello, G.; Mori, D.; Leonardi, F.; Gnetti, L.; Crafa, P.; Sala, R.; Cascinu, S.
Predictive role of body composition parameters in operable breast cancer patients treated with neoadjuvant chemotherapy
2019-01-01 Omarini, C.; Palumbo, P.; Pecchi, A.; Draisci, S.; Balduzzi, S.; Nasso, C.; Barbolini, M.; Isca, C.; Bocconi, A.; Moscetti, L.; Galetti, S.; Tazzioli, G.; Torricelli, P.; Cascinu, S.; Piacentini, F.
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes
2020-01-01 Loupakis, F.; Depetris, I.; Biason, P.; Intini, R.; Prete, A. A.; Leone, F.; Lombardi, P.; Filippi, R.; Spallanzani, A.; Cascinu, S.; Bonetti, L. R.; Maddalena, G.; Valeri, N.; Sottoriva, A.; Zapata, L.; Salmaso, R.; Munari, G.; Rugge, M.; Dei Tos, A. P.; Golovato, J.; Sanborn, J. Z.; Nguyen, A.; Schirripa, M.; Zagonel, V.; Lonardi, S.; Fassan, M.
Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study
2020-01-01 Van Cutsem, E.; Muro, K.; Cunningham, D.; Bodoky, G.; Sobrero, A.; Cascinu, S.; Ajani, J.; Oh, S. C.; Al-Batran, S. E.; Wainberg, Z. A.; Wijayawardana, S. R.; Melemed, S.; Ferry, D.; Hozak, R. R.; Ohtsu, A.
Imaging and clinical correlates with regorafenib in metastatic colorectal cancer
2020-01-01 Khan, K.; Cascinu, S.; Cunningham, D.; Kim, S. -Y.; Oki, E.; Seery, T.; Shen, L.; Siena, S.; Tournigand, C.; Turhal, N. S.; Hendlisz, A.
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference
2020-01-01 Roberto, M.; Marchetti, P.; Arrivi, G.; Di Pietro, F. R.; Cascinu, S.; Gelsomino, F.; Caputo, F.; Cerma, K.; Ghidini, M.; Ratti, M.; Pizzo, C.; Ficorella, C.; Parisi, A.; Cortellini, A.; Urbano, F.; Calandrella, M. L.; Botticelli, A.; Dell'Aquila, E.; Minelli, A.; Fulgenzi, C.; Montori, A.; Pilozzi, E.; Mazzuca, F.
From central to sentral (Serum angiogenesis central): Circulating predictive biomarkers to anti-VEGFR therapy
2020-01-01 Giampieri, R.; Ziranu, P.; Daniele, B.; Zizzi, A.; Ferrari, D.; Lonardi, S.; Zaniboni, A.; Cavanna, L.; Rosati, G.; Casagrande, M.; Pella, N.; Demurtas, L.; Zampino, M. G.; Sozzi, P.; Pusceddu, V.; Germano, D.; Lai, E.; Zagonel, V.; Codeca, C.; Libertini, M.; Puzzoni, M.; Labianca, R.; Cascinu, S.; Scartozzi, M.
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach
2020-01-01 Berardi, R.; Goteri, G.; Brunelli, A.; Pagliaretta, S.; Paolucci, V.; Caramanti, M.; Rinaldi, S.; Refai, M.; Pompili, C.; Morgese, F.; Torniai, M.; Marcantognini, G.; Ricci, G.; Mazzanti, P.; Onofri, A.; Bianchi, F.; Sabbatini, A.; Cascinu, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab | 1-gen-2017 | Demurtas, L.; Puzzoni, M.; Giampieri, R.; Ziranu, P.; Pusceddu, V.; Mandolesi, A.; Cremolini, C.; Masi, G.; Gelsomino, F.; Antoniotti, C.; Loretelli, C.; Meriggi, F.; Zaniboni, A.; Falcone, A.; Cascinu, S.; Scartozzi, M. | |
| Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW | 1-gen-2018 | Muro, K.; Cho, J. Y.; Bodoky, G.; Goswami, C.; Chao, Y.; dos Santos, L. V.; Shimada, Y.; Topuzov, E.; Van Cutsem, E.; Tabernero, J.; Zalcberg, J.; Chau, I.; Cascinu, S.; Cheng, R.; Hsu, Y.; Emig, M.; Orlando, M.; Fuchs, C. | |
| Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials | 1-gen-2018 | Coccolini, F.; Nardi, M.; Montori, G.; Ceresoli, M.; Celotti, A.; Cascinu, S.; Fugazzola, P.; Tomasoni, M.; Glehen, O.; Catena, F.; Yonemura, Y.; Ansaloni, L. | |
| An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study | 1-gen-2018 | Lazzaro, C.; Barone, C.; Caprioni, F.; Cascinu, S.; Falcone, A.; Maiello, E.; Milella, M.; Pinto, C.; Reni, M.; Tortora, G. | |
| Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study | 1-gen-2019 | Van Cutsem, E.; Martinelli, E.; Cascinu, S.; Sobrero, A.; Banzi, M.; Seitz, J. -F.; Barone, C.; Ychou, M.; Peeters, M.; Brenner, B.; Hofheinz, R. D.; Maiello, E.; Andre, T.; Spallanzani, A.; Garcia-Carbonero, R.; Arriaga, Y. E.; Verma, U.; Grothey, A.; Kappeler, C.; Miriyala, A.; Kalmus, J.; Falcone, A.; Zaniboni, A. | |
| The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials | 1-gen-2019 | Cascinu, S.; Poli, D.; Zaniboni, A.; Lonardi, S.; Labianca, R.; Sobrero, A.; Rosati, G.; Di Bartolomeo, M.; Scartozzi, M.; Zagonel, V.; Pella, N.; Banzi, M.; Torri, V. | |
| Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series | 1-gen-2019 | Negri, F.; De Giorgi, A.; Gilli, A.; Azzoni, C.; Bottarelli, L.; Gnetti, L.; Goldoni, M.; Manotti, L.; Sgargi, P.; Michiara, M.; Leonardi, F.; Rindi, G.; Cascinu, S.; Silini, E. M. | |
| Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy | 1-gen-2019 | Giampieri, R.; Piva, F.; Occhipinti, G.; Bittoni, A.; Righetti, A.; Pagliaretta, S.; Murrone, A.; Bianchi, F.; Amantini, C.; Giulietti, M.; Ricci, G.; Principato, G.; Santoni, G.; Berardi, R.; Cascinu, S. | |
| Is there a role for chemotherapy after local relapse in high-grade osteosarcoma? | 1-gen-2019 | Palmerini, E.; Torricelli, E.; Cascinu, S.; Pierini, M.; De Paolis, M.; Donati, D.; Cesari, M.; Longhi, A.; Abate, M.; Paioli, A.; Setola, E.; Ferrari, S. | |
| The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy | 1-gen-2019 | Salati, M.; Caputo, F.; Cunningham, D.; Marcheselli, L.; Spallanzani, A.; Rimini, M.; Gelsomino, F.; Reggiani-Bonetti, L.; Andrikou, K.; Rovinelli, F.; Smyth, E.; Baratelli, C.; Kouvelakis, K.; Kalaitzaki, R.; Gillbanks, A.; Michalarea, V.; Cascinu, S.; Braconi, C. | |
| A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study | 1-gen-2019 | Loupakis, F.; Intini, R.; Cremolini, C.; Orlandi, A.; Sartore-Bianchi, A.; Pietrantonio, F.; Pella, N.; Spallanzani, A.; Dell'Aquila, E.; Scartozzi, M.; De Luca, E.; Rimassa, L.; Formica, V.; Leone, F.; Calvetti, L.; Aprile, G.; Antonuzzo, L.; Urbano, F.; Prenen, H.; Negri, F.; Di Donato, S.; Buonandi, P.; Tomasello, G.; Avallone, A.; Zustovich, F.; Moretto, R.; Antoniotti, C.; Salvatore, L.; Calegari, M. A.; Siena, S.; Morano, F.; Ongaro, E.; Cascinu, S.; Santini, D.; Ziranu, P.; Schirripa, M.; Buggin, F.; Prete, A. A.; Depetris, I.; Biason, P.; Lonardi, S.; Zagonel, V.; Fassan, M.; Di Maio, M. | |
| A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients | 1-gen-2019 | Weide, B.; Eigentler, T.; Catania, C.; Ascierto, P. A.; Cascinu, S.; Becker, J. C.; Hauschild, A.; Romanini, A.; Danielli, R.; Dummer, R.; Trefzer, U.; Elia, G.; Neri, D.; Garbe, C. | |
| High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer | 1-gen-2019 | Negri, F.; Bozzetti, C.; Pedrazzi, G.; Azzoni, C.; Bottarelli, L.; Squadrilli, A.; Lagrasta, C.; Tamagnini, I.; Bisagni, A.; Ragazzi, M.; Porzio, R.; Tomasello, G.; Mori, D.; Leonardi, F.; Gnetti, L.; Crafa, P.; Sala, R.; Cascinu, S. | |
| Predictive role of body composition parameters in operable breast cancer patients treated with neoadjuvant chemotherapy | 1-gen-2019 | Omarini, C.; Palumbo, P.; Pecchi, A.; Draisci, S.; Balduzzi, S.; Nasso, C.; Barbolini, M.; Isca, C.; Bocconi, A.; Moscetti, L.; Galetti, S.; Tazzioli, G.; Torricelli, P.; Cascinu, S.; Piacentini, F. | |
| Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes | 1-gen-2020 | Loupakis, F.; Depetris, I.; Biason, P.; Intini, R.; Prete, A. A.; Leone, F.; Lombardi, P.; Filippi, R.; Spallanzani, A.; Cascinu, S.; Bonetti, L. R.; Maddalena, G.; Valeri, N.; Sottoriva, A.; Zapata, L.; Salmaso, R.; Munari, G.; Rugge, M.; Dei Tos, A. P.; Golovato, J.; Sanborn, J. Z.; Nguyen, A.; Schirripa, M.; Zagonel, V.; Lonardi, S.; Fassan, M. | |
| Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study | 1-gen-2020 | Van Cutsem, E.; Muro, K.; Cunningham, D.; Bodoky, G.; Sobrero, A.; Cascinu, S.; Ajani, J.; Oh, S. C.; Al-Batran, S. E.; Wainberg, Z. A.; Wijayawardana, S. R.; Melemed, S.; Ferry, D.; Hozak, R. R.; Ohtsu, A. | |
| Imaging and clinical correlates with regorafenib in metastatic colorectal cancer | 1-gen-2020 | Khan, K.; Cascinu, S.; Cunningham, D.; Kim, S. -Y.; Oki, E.; Seery, T.; Shen, L.; Siena, S.; Tournigand, C.; Turhal, N. S.; Hendlisz, A. | |
| The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference | 1-gen-2020 | Roberto, M.; Marchetti, P.; Arrivi, G.; Di Pietro, F. R.; Cascinu, S.; Gelsomino, F.; Caputo, F.; Cerma, K.; Ghidini, M.; Ratti, M.; Pizzo, C.; Ficorella, C.; Parisi, A.; Cortellini, A.; Urbano, F.; Calandrella, M. L.; Botticelli, A.; Dell'Aquila, E.; Minelli, A.; Fulgenzi, C.; Montori, A.; Pilozzi, E.; Mazzuca, F. | |
| From central to sentral (Serum angiogenesis central): Circulating predictive biomarkers to anti-VEGFR therapy | 1-gen-2020 | Giampieri, R.; Ziranu, P.; Daniele, B.; Zizzi, A.; Ferrari, D.; Lonardi, S.; Zaniboni, A.; Cavanna, L.; Rosati, G.; Casagrande, M.; Pella, N.; Demurtas, L.; Zampino, M. G.; Sozzi, P.; Pusceddu, V.; Germano, D.; Lai, E.; Zagonel, V.; Codeca, C.; Libertini, M.; Puzzoni, M.; Labianca, R.; Cascinu, S.; Scartozzi, M. | |
| Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach | 1-gen-2020 | Berardi, R.; Goteri, G.; Brunelli, A.; Pagliaretta, S.; Paolucci, V.; Caramanti, M.; Rinaldi, S.; Refai, M.; Pompili, C.; Morgese, F.; Torniai, M.; Marcantognini, G.; Ricci, G.; Mazzanti, P.; Onofri, A.; Bianchi, F.; Sabbatini, A.; Cascinu, S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39411
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711498
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.771
- John Wiley and Sons Inc525
- Springer Science and Business Med...522
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer362
- MDPI347
- Elsevier Ltd330
- Springer Nature282
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28818
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33631
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1